CapsoVision director exercises 2,022 RSUs

CapsoVision, Inc director Joanne Carol Imperial reported a routine equity compensation event.

Rhea-AI Filing Summary

CapsoVision, Inc director Joanne Carol Imperial reported a routine equity compensation event. On June 30, she exercised previously granted Restricted Stock Units (RSUs), receiving 2,022 shares of common stock at no cash cost to her as part of an equity incentive grant.

The filing shows she now directly owns 3,709 shares of CapsoVision common stock. The RSU award was originally granted on March 19, 2026 using a fair market value of $6.18 per share, and vests in two installments each year, with this report reflecting the June 30 vesting portion.

Insider Trade Summary

2,022 shares exercised/converted

Exercise 2 txns

Insider Imperial Joanne Carol

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit (RSU)	2,022	$0.00	$0.00
Exercise	Common Stock	2,022	$7.58	$15K

Holdings After Transaction: Restricted Stock Unit (RSU) — 2,023 contracts (Direct); Common Stock — 3,709 shares (Direct)

Footnotes (2)

1. F1. Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.
2. F2. The Restricted Stock Units (RSUs), the conversion of which are reported herein, were granted to the Reporting Person by the issuer as part of equity incentive grants made by the issuer on 3/19/2026 utilizing a fair market value (FMV) of a share of the issuers stock of $6.18. The RSU grant vests as to 50% of the RSUs subject to the award on June 30 of the applicable year and as to 50% of the RSUs subject to the award on December 31 of that year. This report reflects the vesting of one-half portion of the original RSU grant and the acquisition by the Reporting Person of the underlying shares.

Key Figures

RSUs converted: 2,022 shares Price per share (common stock line): $7.58/share Fair market value at grant: $6.18/share +2 more

5 metrics

RSUs converted 2,022 shares RSUs converted into common stock on June 30, 2026

Price per share (common stock line) $7.58/share Transaction price per share reported for common stock entry

Fair market value at grant $6.18/share FMV used for RSU grant on March 19, 2026

Shares held after transaction 3,709 shares Total direct common stock holdings after RSU conversion

RSUs remaining after transaction 2,023 RSUs Total RSUs reported following transaction

Key Terms

Restricted Stock Unit (RSU), equity incentive grants, fair market value (FMV), Exercise or conversion of derivative security

4 terms

Restricted Stock Unit (RSU) financial

"The Restricted Stock Units (RSUs), the conversion of which are reported herein, were granted..."

A restricted stock unit (RSU) is a promise from a company to give an employee company shares (or cash equal to their value) at a future date if certain conditions are met, such as staying with the company or hitting performance targets. For investors, RSUs matter because when they convert into actual shares they increase the number of shares available and can create selling pressure as employees cash out—think of them as a future paycheck paid in company stock.

equity incentive grants financial

"were granted to the Reporting Person by the issuer as part of equity incentive grants..."

fair market value (FMV) financial

"utilizing a fair market value (FMV) of a share of the issuers stock of $6.18."

Exercise or conversion of derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CapsoVision (CV) disclose for Joanne Carol Imperial?

CapsoVision disclosed that director Joanne Carol Imperial acquired 2,022 shares of common stock through the vesting and conversion of Restricted Stock Units. This was a compensation-related derivative exercise, not an open-market purchase or sale of shares.

How many CapsoVision (CV) shares does Joanne Carol Imperial hold after this Form 4?

After the RSU conversion, Joanne Carol Imperial directly holds 3,709 shares of CapsoVision common stock. This reflects the addition of 2,022 newly issued shares from vested RSUs to her prior holdings, as reported in the Form 4 filing.

What was the size and nature of the RSU grant reported by CapsoVision (CV)?

The filing reports RSUs converting into 2,022 common shares as part of an equity incentive grant made on March 19, 2026. The grant used a fair market value of $6.18 per share and vests in two installments each calendar year.

Did Joanne Carol Imperial buy or sell CapsoVision (CV) shares on the market?

The Form 4 does not show any open-market buying or selling. It reports an M-code transaction, indicating the exercise or conversion of RSUs into 2,022 common shares as compensation, rather than a purchase or sale on a stock exchange.

How do the CapsoVision (CV) RSUs for Joanne Carol Imperial vest over time?

According to the footnotes, the RSU grant vests 50% on June 30 and 50% on December 31 of the applicable year. This Form 4 reflects vesting of the June 30 portion, which converted 2,022 RSUs into common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 09:22 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Imperial Joanne Carol

(Last) (First) (Middle)

C/O CAPSOVISION, INC.

18805 COX AVENUE, SUITE 250

(Street)

SARATOGA CALIFORNIA 95070

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CapsoVision, Inc [ CV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	06/30/2026		M		2,022	A	$7.58	3,709	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit (RSU)	$0	06/30/2026		M			2,022	(2)	(2)	Common Stock	2,022	$0	2,023	D

Explanation of Responses:

1. Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.

2. The Restricted Stock Units (RSUs), the conversion of which are reported herein, were granted to the Reporting Person by the issuer as part of equity incentive grants made by the issuer on 3/19/2026 utilizing a fair market value (FMV) of a share of the issuers stock of $6.18. The RSU grant vests as to 50% of the RSUs subject to the award on June 30 of the applicable year and as to 50% of the RSUs subject to the award on December 31 of that year. This report reflects the vesting of one-half portion of the original RSU grant and the acquisition by the Reporting Person of the underlying shares.

Remarks:

	/s/ Kang-Huai (Johnny) Wang, Attorney-in-Fact for Joanne Imperial	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)